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Summary
We present a theoretical basis for testing related endpoints. Typically, it is known how
to construct tests of the individual hypotheses, and the problem is how to combine them into
a multiple test procedure that controls the familywise error rate. Using the closure method,
we emphasize the role of consonant procedures, from an interpretive as well as a theoretical
viewpoint. Suprisingly, even if each intersection test has an optimality property, the overall
procedure obtained by applying closure to these tests may be inadmissible. We introduce a
new procedure, which is consonant and has a maximin property under the normal model. The
results are then applied to PROactive, a clinical trial designed to investigate the effectiveness
of a glucose-lowering drug on macrovascular outcomes among patients with type 2 diabetes.
Some key words: Closure method; Consonance; Familywise error rate; Multiple
endpoints; Multiple testing; O’Brien’s method.
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1 Introduction
In research and experimentation it is common to specify several hypotheses. In clinical research,
these have been characterized as primary, usually one hypothesis or ‘endpoint’, and secondary,
one or more endpoints to be tested if the primary endpoint is significant. More frequently
now, clinical trials feature multiple, co-primary endpoints, the significance of any of which
forms the basis for a claim of efficacy. Therefore, for both scientific and regulatory reasons, the
familywise error rate for the family of co-primary endpoints is to be controlled. Furthermore, it
may be reasonable to expect that every co-primary endpoint will exhibit an effect of treatment,
possibly some to a greater degree than others. This is the common effect direction alluded to
in the title.
The desire to focus power on a common direction led O’Brien (1984) to combine multiple
test statistics into a single hypothesis test. Under a normal model assumption, O’Brien derived
an ordinary least squares test statistic and a generalized least squares test statistic that are
more powerful than Hotelling’s T 2 statistic in the case of related endpoints. Lehmacher et
al. (1991) apply O’Brien’s test in combination with the closure principle of Marcus et.al.
(1976). They point out that the Bonferroni test, and by extension, stepdown tests based
on the maximum test statistic (Romano and Wolf, 2005), is useful for detecting one highly
significant difference, or treatment effect, among a group of otherwise barely significant or
nonsignificant differences. On the other hand, O’Brien’s tests, based on the unweighted or
weighted sum of test statistics, succeed in rejecting the global null against alternatives closer
to the diagonal, by what is meant a group of similar treatment effects. Pocock et al. (1987)
extend this approach to a general situation of asymptotically normal test statistics. Summing
test statistics in the multivariate survival analysis setting, as we do in the example later,
became theoretically justified with the method of Wei et al. (1989). The main problem we
consider is how to combine tests of individual hypotheses into a multiple testing procedure
that is sensitive or powerful when the endpoints are related.
Data X are available, whose distribution is given by a model P = {Pθ, θ ∈ Ω}. The
parameter space Ω can be parametric, semiparametric or nonparametric, since θ merely indexes
the parameter space. In order to devise a procedure which controls the familywise error rate,
the closure method reduces the problem to constructing tests that control the usual probability
of Type 1 error. To be specific, for a subset K ⊆ {1, . . . , s} and ωi ⊂ Ω, let HK denote the
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intersection hypothesis defined by
HK = ωK ≡
⋂
i∈K
ωi ; (1)
that is, HK is true if and only if θ ∈
⋂
i∈K ωi. Of course, Hi = H{i}. Suppose that φK is an
α-level test of HK ; that is, supθ∈ωK Eθ{φK(X)} 6 α. Then the decision rule that rejects Hi if
HK is rejected for all subsets K for which {i} ⊆ K strongly controls the familywise error rate.
Consider the choice of tests of HK . Even in the case s = 2, little formal theory exists in
the design of tests of HK , but many ad hoc procedures have been developed; see Hochberg &
Tamhane (1987), Westfall & Young (1993), Romano & Wolf (2005) and the references therein.
These approaches incorporate the dependence structure of the data and improve on Holm’s
(1979) method.
Stepdown tests based on the maximum test statistic yield multiple test procedures which
satisfy a property called consonance; for a discussion of such tests see Remark 2 or Romano &
Wolf (2005). A testing method is consonant when the rejection of an intersection hypothesis
implies the rejection of at least one of its component hypotheses. An associated concept is
that of coherence, which states that the non-rejection of an intersection hypothesis implies
the non-rejection of any subset hypothesis it implies. Coherence is de facto true in any closed
testing method. Consider a randomized experiment for testing the efficacy of a drug versus a
placebo with two primary endpoints in a closed test setting: testing for reduction in headaches,
H1, and testing for reduction in muscle pain, H2. If the joint intersection hypothesis H{1,2}
is rejected but neither individual hypothesis is rejected, then one might conclude that the
drug has some beneficial effect, but compelling evidence has not been established to promote a
particular drug indication. Lack of consonance, which is alternatively called dissonance, makes
interpretation awkward. Moreover, we will argue that, in the framework we are concerned
with here, dissonance is undesirable in that it results in decreased ability to reject false null
hypotheses.
Sonnemann & Finner (1988) showed that any incoherent procedure can be replaced by
a coherent one which is at least as good. Sonnemann (1982) also showed that all coherent
procedures which control the familywise error rate must be obtained by the closure method.
Therefore, our restriction to procedures based on the closure method is no restriction at all.
Moreover, it can be shown, in unpublished work by one of the authors, that any procedure
that is not consonant can be replaced by a consonant one which is at least as good, in the
sense that the familywise error rate is still controlled and there are at least as many rejections
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as the original procedure. This paper provides an explicit construction that yields a strict
improvement over existing methods in the context of testing multiple endpoints with common
effect direction.
2 Rationale for the Sum Test
In this section, we consider a stylized version of the problem. The parametric structure we
now assume is an asymptotic approximation to the more general nonparametric framework.
Think of Xi as denoting a test statistic for the ith hypothesis, and assume that (X1, . . . ,Xs) is
multivariate normal with Xi ∼ N(θi, 1) and known covariance matrix Σ. Let θ = (θ1, . . . , θs).
For testing one-sided alternatives in this parametric model, the parameter space is given by
Ω = {θ :
s⋂
i=1
{θi > 0}} . (2)
However, we will also consider two-sided alternatives, but with the restriction that alternatives
(θ1, . . . , θs) are such that all θi have the same sign, possibly negative; that is, we will also later
consider the larger parameter space
Ω′ = {θ :
s⋂
i=1
{θi > 0}}
⋃
{θ :
s⋂
i=1
{θi 6 0}} . (3)
For testing Hi : θi = 0 against θi > 0, the test that rejects Hi if Xi > z1−α is uniformly most
powerful level α. In order to apply closure, we consider tests of the intersection hypothesis
θi = 0 for all i. The general intersection hypothesis HK given in (1) can be handled in the
same way by just considering i ∈ K.
Proposition 1. Consider the multivariate location model with mean vector θ ∈ Ω and known
nonsingular covariance matrix Σ, where the parameter space Ω is given by (2). Then
(i) for testing θi = 0 for all i against the fixed alternative (θ
′
1, . . . , θ
′
s), the most powerful
test rejects for large values of (θ′)TΣ−1X, where X is a column vector with transpose XT =
(X1, . . . ,Xs) and θ
′ is a column vector with transpose (θ′)T = (θ′1, . . . , θ
′
s). In particular, no
uniformly most powerful test exists;
(ii) for testing θi = 0 for all i against alternatives (θ
′
1, . . . , θ
′
s) such that all θ
′
i are equal, a
uniformly most powerful test exists and rejects for large values of the sum of the components
of Σ−1X;
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(iii) if, in addition, Σ has diagonal elements 1 and off-diagonal elements ρ, then a uniformly
most powerful level α test exists and rejects the hypothesis that all θi = 0 when
∑
iXi >
z1−α{s+ s(s− 1)ρ}
1/2.
All proofs are given in the Appendix. Thus, rejecting the intersection hypothesis for large
values of the sum
∑
iXi is uniformly most powerful, but only for a restricted alternative
parameter space, and under a strong assumption on Σ. We now obtain a maximin result that
applies to a much larger alternative parameter space.
Proposition 2. Assume that Σ has diagonal elements 1 and off-diagonal elements ρ, and
consider testing H0 : θ = (0, 0, . . . , 0) against θ ∈ ω1(ǫ), where
ω1(ǫ) = {θ :
⋂
i
{θi > ǫ}} . (4)
Then the test that rejects when
∑
iXi > z1−α{s+s(s−1)ρ}
1/2 is maximin; that is, it maximizes
inf{θ ∈ ω1(ǫ) : prθ{reject H0}}.
Remark 1. The covariance structure of Proposition 2, known as ‘compound symmetry’, is a
tractable correlation model that is used in a number of practical situations, such as repeated
measures analysis of variance. Unfortunately, if Σ has a different structure, the less tractable
linear combination 1′Σ−1X is maximin. Note the similarity of this test statistic, derived here
by testing and maximizing power, to O’Brien’s (1984, p. 1082) best linear unbiased estimator
of the common mean of possibly correlated random variables.
Finally, for two-sided alternatives with parameter space Ω′ given in (3), an analogous
maximin result holds for the test that rejects for large values of |
∑
Xi|.
3 Optimal Consonant Tests
Formally, with consonant methods, if the intersection hypothesis HK defined in (1) is rejected,
then some Hi with i ∈ K is rejected. We concentrate now on how to choose consonant tests
of an intersection hypothesis. What follows is an example of a dissonant test.
Example 1: One-sided normal means. Recall the set-up in §2 and Proposition 2. If α = 0.05,
ρ = 0 and (X1,X2) = (1.4, 1.4), then no Hi can be rejected by closure, even though H{1,2} is
rejected because the sum test rejects if X1 +X2 > 2.326; see Fig 1.
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This procedure can be improved if the goal is to make correct decisions about H1 and H2.
To appreciate why, note that there are points in the rejection region for testing the intersection
hypothesis H{1,2} that do not allow for rejection of either H1 or H2. By removing such points
from the rejection region when testing H{1,2}, we can instead include other points in the rejec-
tion region that satisfy the constraint that the overall rule be consonant, while still maintaining
error control. To achieve that for our overall test of H{1,2}, we restrict attention to tests that
have a rejection region in the plane which lies entirely in {(X1,X2) : max(X1,X2) > z1−α}.
Any intersection test satisfying this constraint will result in a consonant procedure when ap-
plying the closure method.
To see a concrete way to improve upon the above procedure, consider a rejection region Sα
for H{1,2} of the form
Sα = {(X1,X2) : X1 +X2 > s(1− α), max(Xi) > z1−α} , (5)
where the constant s(1 − α) is determined so that, under (θ1, θ2) = (0, 0), the region Sα has
probability α. The rejection region has been obtained from Proposition 2 by removing points
that do not support consonance and including points that do. The chance of rejecting any
false individual null hypothesis now increases when the closure method is applied. Indeed,
s(1 − α) < 21/2z1−α. For an illustration with α = 0.05, see Fig 1. There, the point A =
(1.4, 1.4) leads to a rejection by the intersection test of Proposition 2 but not by the improved
test; no individual hypotheses are rejected in either case. On the other hand, the point B =
(1.9, 0.25) leads to a rejection by the improved test of Proposition 3 but not by the test of
Proposition 2. It follows in general that, for any i = 1, 2, with θi > 0,
prθ1,θ2{reject Hi using Proposition 2} < prθ1,θ2{reject Hi using Sα} ;
that is, the new consonant procedure has uniformly greater power at detecting a false null
hypothesis Hi than the dissonant procedure using the sum statistic for the intersection test.
Similarly, if both nulls are false, the new procedure has a uniformly greater chance of detecting
both hypotheses as false or at least one false hypothesis. In summary, imposing consonance
makes interpretation easier and provides better discriminating ability.
Thus, applying closure based on intersection tests which each have an optimality property
need not result in an overall optimal procedure for the multiple testing problem. We now
pursue the construction of an optimal choice of the intersection test, which will justify the use
of (5). The following is a modest generalization of the Neyman-Pearson Lemma, where we now
6
impose the added consonance constraint that the rejection region be restricted to a region R
of the sample space.
Lemma 1. Suppose that P0 and P1 are two probability distributions with densities p0 and p1
with respect to a dominating measure. Restrict attention to tests φ = φ(X) that are level α,
that is, E0{φ(X)} 6 α, and such that φ(X) = 0 if X ∈ A, for some fixed region A in the
sample space. Let R = Ac be the complement of A. Among such tests, a test that maximizes
the power against P1 is given by
φ(x) =


1 if L(x) > C and x ∈ R
γ if L(x) = C and x ∈ R
0 if L(x) < 0 or x ∈ A,
(6)
where L(x) = p1(x)/p0(x) and C and γ are chosen to meet the level constraint.
Next, we construct a maximin test by generalizing Theorem 8.1.1 in Lehmann & Romano
(2005), except that now we have the added constraint that the rejection region must lie in some
fixed set R. Denote by ω the null hypothesis parameter space and by ω′ the alternative hy-
pothesis parameter space over which it is desired to maximize the minimum power. The goal
is to determine the test that maximizes infθ∈ω′ Eθ{φ(X)} subject to supθ∈ω Eθ{φ(X)} 6 α
and to the constraint that the rejection region must lie entirely in a fixed subset R. Let
{Pθ, θ ∈ ω ∪ ω
′} be a family of probability distributions over a sample space (X ,A) with den-
sities pθ = dPθ/dµ with respect to a σ-finite measure µ, and suppose that the densities pθ(x)
considered as functions of the two variables (x, θ) are measurable (A×B) and (A×B′), where
B and B′ are given σ-fields over ω and ω′.
Theorem 1. For any distributions Λ and Λ′ over B and B′, for testing
h(x) =
∫
ω
pθ(x) dΛ(θ)
against
h′(x) =
∫
ω′
pθ(x) dΛ
′(θ) ,
let ϕΛ,Λ′ be the most powerful among level α tests φ that also satisfy φ(x) = 0 if x ∈ R
c. Also,
let βΛ,Λ′, be its power against the alternative h
′. If Λ and Λ′ satisfy
sup
ω
EθϕΛ,Λ′(X) 6 α, inf
ω′
EθϕΛ,Λ′(X) = βΛ,Λ′ , (7)
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then ϕΛ,Λ′ maximizes infω′ Eθϕ(X) among all level-α tests φ(·) of the hypothesis H : θ ∈ ω
which also satisfy φ(x) = 0 if x ∈ Rc, and it is the unique test with this property if it is the
unique most powerful level-α test among tests that accept on Rc for testing h against h′.
Example 2: Continuation of Example 1. Recall that (X1,X2) is bivariate normal with unit
variances, E(Xi) = θi, and known correlation coefficient ρ. The problem is to test the null
hypotheses Hi : θi = 0 against the one-sided alternatives θi > 0. Theorem 1 implies the
following.
Proposition 3. Consider the above multiple testing problem. Apply the closure method using
the test that rejects Hi if Xi > z1−α. The test of H{1,2} which maximizes
inf
ω1(ǫ)
prθ1,θ2{reject at least one Hi}
among procedures controlling the familywise error rate is given by (5), where ω1(ǫ) is given by
(4).
Remark 2: Test based on the maximum test statistic. In the above multiple testing problem,
the test based on the maximum test statistic works as follows. Denote the ordered test statistics
by T(1) ≤ T(2) with corresponding hypotheses H(1) and H(2). Reject H(2) if T(2) > q(1 − α),
where the critical value q(1− α) depends on ρ and satisfies
pr0,0{max(X1,X2) > q(1− α)} = α .
If H(2) is not rejected, stop. Otherwise, further reject H(1) if T(1) > z1−α.
Example 3: Application to restricted two-sided testing. Consider the set-up of §2, except
that now we consider the two-sided case. The full parameter space is given by (3) and Hi
specifies θi = 0. Here, (X1,X2) is bivariate normal with unit variances, E(Xi) = θi and known
correlation coefficient ρ. We now determine the consonant, maximin, level-α test against ω′1(ǫ)
defined by
ω′1(ǫ) = {θ : θi > ǫ , i = 1, 2}
⋃
{θ : θi 6 −ǫ , i = 1, 2} . (8)
Proposition 4. Consider the above multiple testing problem. Apply the closure method using
the test that rejects Hi if |Xi| > z1−α/2. The test of H{1,2} which maximizes
inf
ω′
1
(ǫ)
prθ1,θ2{reject at least one Hi}
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among procedures controlling the familywise error rate is given by
{(X1,X2) : |X1 +X2| > r(1− α), max(|Xi|) > z1−α/2} , (9)
where r(1− α) is determined so that the region has probability α under (θ1, θ2) = (0, 0).
Again, the optimal region takes the same form as the one without restricting to consonant
tests, but just adds the necessary restriction on the rejection region. For an illustration, see
Fig 2. For example, the point C = (1.6, 1.6) leads to a rejection by the absolute sum test,
though no individual Hi is rejected, but not by the improved test of Proposition 4. On the
other hand, the point D = (2.3, 0.2) leads to a rejection by the improved test but not by the
absolute sum test. Table 1 shows the critical values r(0.90), r(0.95) and r(0.99) as functions
of ρ. By symmetry, s(1−α) = r(1− 2α), so some one-sided critical values can also be derived
from the table. The critical values r(1 − α) in Table 1 were obtained by simulation. To
see how, fix α. Draw B random samples from the bivariate normal distribution with means
0, unit variances and correlation coefficient ρ. Call the bth such sample (X∗1 (b),X
∗
2 (b)). If
maxi∈{1,2}(|X
∗
i (b)|) > z1−α/2, let Y (b) = |
∑2
i=1X
∗
i (b)|; otherwise, let Y (b) = 0. Then r(1−α)
is obtained as the empirical 1− α quantile of the B values Y (1), . . . , Y (B).
Table 2 compares αˆ, the empirical familywise error rate, and βˆ, the empirical prθ1,θ2{reject >
1 false Hi}, of the Holm and stepwise maxT tests to the standard Sum and consonant sum,
ConS, tests. Remark 2 provides a definition of the stepwise maxT test in this context; the
corresponding critical values q(1−α) were also obtained by simulation. Each scenario is based
on 50000 simulations from a bivariate normal distribution with mean vector (θ1, θ2), unit vari-
ances and correlation coefficient ρ = 0 and 0.5, with one-sided α = 0.025. Note that maxT
is more powerful than Holm for nonzero ρ, and ConS is always more powerful than Sum. As
expected, maxT is most powerful when there is only one nonzero mean, while ConS is most
powerful when there are two equal nonzero means. With two unequal nonzero means, one
large and one medium-sized, ConS is more powerful for ρ = 0 while maxT is more powerful for
ρ = 0.5. Finally, note that Sum’s empirical familywise error rate sometimes falls quite short
of 0.025 because of its lack of consonance.
Remark 3: Control of directional errors. Suppose that, if Hi is rejected by a given procedure,
such as that of Proposition 4, then we declare θi > 0 if Xi > 0 or θi < 0 if Xi < 0. A directional
error occurs if it is declared that θi < 0 when in fact θi > 0, or if it is declared that θi > 0
when θi < 0. Control of the familywise error rate, ie. Type 1 errors, and directional errors
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together entails showing that, for any (θ1, θ2),
prθ1,θ2{either reject at least one true Hi or make one or more directional errors} 6 α . (10)
Application of the closure method need not result in control of directional errors; see Shaffer
(1980). For some recent literature on directional errors, see Finner (1999) and Shaffer (2002).
In general, the value on the left-hand side of (10) will be no smaller than the probability of
at least one false rejection, the familywise error rate. Simulations over a wide range of (θ1, θ2)
and ρ support the validity of (10) for our procedure. However, we can only argue that the
procedure based on Proposition 4 satisfies (10) if α is replaced by 3α/2. If both Hi are true,
there is nothing to prove, since (10) is then covered by familywise error rate control. Next,
suppose that both Hi are false. If both θi are less than 0, then the left-hand side of (10) does
not exceed
prθ1,θ2{at least one Xi > z1−α/2},
which by Bonferroni’s inequality is no bigger than
prθ1{X1 > z1−α/2}+ prθ2{X2 > z1−α/2} .
However, each term is bounded above by the same expression with θi replaced by 0, since
θi < 0, leading to the upper bound α. A similar argument holds if one θi is positive and the
other negative, or if both are positive. The final case occurs if one Hi is true and the other
false. Assume without loss of generality that θ1 = 0 and θ2 < 0. Then the event that H1 is
rejected or θ2 is declared positive implies either |X1| > z1−α/2 or X2 > z1−α/2. By Bonferroni,
the probability of the union of these events under (0, θ2) is bounded above by
pr0,θ2{|X1| > z1−α/2}+ pr0,θ2{X2 > z1−α/2}
The first term equals α, and the second term is bounded above by the same expression with
θ2 replaced by 0, yielding α/2. The sum 3α/2 is the bound.
Remark 4: General s. The previous results generalize to s hypotheses. For example, consider
Example 3, but now for general s. Let (X1, . . . ,Xs) be multivariate normal with known
covariance matrix Σ and mean vector (θ1, . . . , θs). The parameter space consists of Ω
′ given
by (3). Assume that Σ has all off-diagonal elements equal to ρ and diagonal elements equal to
one. The test that rejects for large values of |
∑
Xi| is maximin, but, if used for testing the
intersection hypothesis that all θi = 0, application of the closure method does not result in
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a consonant procedure. To see how closure leads to an improved multiple testing procedure,
first test individual hypotheses Hi by rejecting Hi if |Xi| > z1−α/2. For testing the general
intersection hypothesis HK , which specifies θi = 0 for i ∈ K, consider the following test with
rejection region
Rα,K ≡ {(X1, . . . ,Xs) : |
∑
i∈K
Xi| > r(1− α,K), and at least one Hi, i ∈ K
is rejected when applying closure to the family {Hi, i ∈ K}},
where the critical value r(1− α,K) is determined so that the above region has probability at
most α when θi = 0 for all i. Evidently, the critical values r(1 − α,K) must be determined
inductively, so that, in order to determine r(1− α,K), we first determine r(1− α,K ′) for all
K ′ ⊂ K. The test HK is maximin among level α tests which satisfy the consonant constraint
that the rejection region Rα,K must lie in
⋃
K ′⊂K Rα,K ′ . Critical values may be approximated
by simulation similar to the case s = 2. Note that r(1 − α,K) does not depend on s and
depends on K only through |K|.
4 Application to the PROactive Clinical Trial
To illustrate the concepts developed here, we use data from PROactive, which stands for
PROspective pioglitAzone Clinical Trial In macroVascular Events, a randomized, double-blind
clinical trial designed to investigate prospectively the effect of an oral glucose-lowering drug on
macrovascular outcomes (Dormandy et al., 2005). The study enrolled 5238 patients with type
2 diabetes and evidence of macrovascular disease from 19 European countries. Patients were
randomly assigned to either pioglitazone treatment or a placebo and were allowed to remain
on whatever other anti-diabetic medication they were taking at the start of the study, except
for other agents in pioglitazone’s class, as well as specific cardiovascular and lipid-altering
medications. The PROactive study aimed to achieve significance in a primary composite
endpoint, the time to first occurrence of any of seven events: death, non-fatal myocardial
infarction, including silent myocardial infarction, stroke, major leg amputation, acute coronary
syndrome, leg revascularization and cardiac intervention, including coronary artery bypass
graft or percutaneous coronary intervention. A second endpoint was also of interest, and
consisted of a subset of the primary events: time to first occurrence among death, non-fatal
myocardial infarction, excluding silent myocardial infarction, and stroke. More information on
the PROactive trial can be found in the website www.proactive-results.com/index.htm.
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Two interim analyses were performed using an alpha spending function, which reduced
the nominal familywise error rate available at the end of the study to 0.044 from the original
0.05. After completion of the three-year study, the log-rank test (Lachin, 2000) of the primary
endpoint yielded a p-value of 0.095. The log-rank test of the principal secondary endpoint
yielded a corresponding p-value of 0.027. While Dormandy et al. (2005) claimed a significant
outcome, critics such as Freemantle (2005) countered that a secondary endpoint cannot be
deemed significant in the absence of a significant outcome in the primary endpoint, an assertion
supported by Chi (1998) among others. However, if we viewed both endpoints as corresponding
to hypotheses of equal interest, rather than tiered as ‘primary’ and ‘secondary’, that is, if we
consider the endpoints to be ‘co-primary’, significance of the second, rather than secondary,
endpoint could be scientifically assessed through a testing strategy that controls the familywise
error rate. At the time of study design the primary endpoint was defined and recognized as
clinically relevant, under the assumption that all vascular beds would be equally affected by
the disease state. However, the clinical relevance of the secondary endpoint was also apparent.
Would the second endpoint have attained significance had the testing methods set forth in this
article been applied?
The closed family of tests for this example consists of the tests of hypotheses H1 and H2 of
the respective co-primary endpoints and the global null hypothesis H{1,2} that neither endpoint
exhibits a treatment effect. Results from tests of H1 and H2 are already available from the
log-rank tests, as outlined above. Thus we proceed to test the intersection hypothesis H{1,2}
by applying the methods of this paper, and note that, if our test produces a p-value less than
or equal to 0.044, the second endpoint could have been declared significant, not by ignoring
the multiplicity problem, but by proper control of the familywise error rate.
The now-co-primary endpoints are clearly related and highly correlated, sharing the com-
mon components of death, non-fatal myocardial infarction and stroke. Even before results were
published, we would have expected a treatment effect, if there were one, to be apparent in both
endpoints. If we want a test of H{1,2} that directs power in the direction of our alternative
hypothesis of a common effect direction, in the region ω′1(ǫ) of (8), the absolute sum test or its
modified consonant maximin sum test of Proposition 4 are the obvious choices.
Since the log-rank test statistics are available, our first inclination might be to sum them.
However, in the case of no ties, Cox (1972) derived the log-rank test as an efficient score test
in a proportional hazards regression model with a single binary covariate for treatment group;
see Lachin (2000). This equivalence with the proportional hazards model, which holds ap-
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proximately if there are relatively few ties, allows us instead to sum the studentized parameter
estimates in a simple fit of the Wei et al. (1989) marginal model with two endpoints, a relatively
simple task in SAS. This sum can represent an overall treatment effect, as measured by the
proportional hazards model, and corresponds to the sum of the logs of the hazard ratios. Wei
et al. (1989) showed that these estimators, based on the endpoint-specific partial likelihoods,
are approximately normal for large sample sizes.
Let η be the vector of s = 2 parameters in the Wei et al. (1989) marginal model. From
the robust covariance matrix (Liang & Zeger, 1986) output by SAS, we estimate the standard
errors as well as the correlation between the parameter estimates, ρˆ = 0.74. Studentizing the
parameter estimates as Xi = ηˆi/SE(ηˆi) yields X1 = −1.667 and X2 = −2.202. We test the
intersection hypothesis H{1,2} : η1 = η2 = 0 by forming, as in Proposition 2, the test statistic
(X1+X2)/(2+2ρˆ)
1/2 = −2.073. The probability of a larger absolute value under the standard
normal is 0.038. Since it is below 0.044, the available α, we reject the intersection hypothesis
and, by the closure principle, claim that the second endpoint indeed had a significant treatment
effect, even after accounting for multiple testing.
However, what result would be obtained from the PROactive data if we applied the con-
sonant maximin sum test of Proposition 4? To calculate the critical value for this test we
drew B = 50000 random samples from the bivariate normal (0, 0, 1, 1) distribution with cor-
relation coefficient 0.74, the observed correlation between the Wei et al. (1989) parameter
estimates. Following the approach of Example 3, we generated the approximate quantile
r(1− 0.044) = 3.700; a linearly interpolated value from Table 1, at ρ = 0.74, is roughly 3.768,
somewhat far from the value generated through simulation, as these critical values are quite
nonlinear in the inputs, especially in the level. The sum of the studentized parameter estimates
has absolute value 3.869, corresponding to a p-value of 0.036. Hence, we can again reject H{1,2}
and by consonance claim significance of the second endpoint.
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Appendix
Proof of Proposition 1. The proof is an application of the Neyman-Pearson Lemma. 
Proof of Proposition 2. The least favourable distribution concentrates on the single point
(ǫ, . . . , ǫ). Maximinity results because the resulting test against this fixed alternative has an
increasing power function in each of the components θi, and therefore the power is minimized
over ω1(ǫ) at (ǫ, . . . , ǫ). 
Proof of Lemma 1. The goal is to maximize EP1 [φ(X)I{X ∈ R}] subject to EP0 [φ(X)I{X ∈
R}] 6 α. Let Qi denote the conditional distribution of X given X ∈ R when X ∼ Pi. Also,
let βi = Pi{R}. Then, equivalently, the problem is to maximize β1
−1EQ1{φ(X)} subject to
EQ0{φ(X)} 6 α/β0, or equivalently maximize EQ1{φ(X)} subject to EQ0{φ(X)} 6 α
′ = α/β0.
By the Neyman Pearson Lemma, the optimal test rejects for large values of the likelihood ratio
dQ1(X)/dQ0(X), which is a constant multiple of L(X). 
Proof of Theorem 1. If ϕ∗ is any other level-α test of H satisfying ϕ∗(X) = 0 if X ∈ Rc,
it is also of level α for testing the simple hypothesis that the density of X is h; therefore, the
power of ϕ∗ against h′ cannot exceed βΛ,Λ′ . It follows that
inf
ω′
Eθϕ
∗(X) 6
∫
ω′
Eθϕ
∗(X) dΛ′(θ) 6 βΛ,Λ′ = inf
ω′
EθϕΛΛ′(X),
and the second inequality is strict if ϕΛΛ′ is unique. 
Proof of Proposition 3. Consider any other method based on closure which rejects Hi if
Xi > z1−α and controls the familywise error rate. Let S
′ denote its rejection region for H{1,2}.
Furthermore, let S′′ = S′ ∩ R, where R = {(X1,X2) : min(Xi) > z1−α}. Then, using S
′
or S′′ results in the same outcomes for the individual tests of Hi as far as the closure method
is concerned. In particular, the probability of rejecting at least one Hi using S
′, combined
with closure, is the same as the probability of rejecting at least one Hi using S
′′. However,
for S′′ ⊂ R, the procedure is now consonant and the probability of rejecting at least one Hi
is the same as the probability of just rejecting the intersection hypothesis based on S′′. The
optimal choice for S′′ is therefore given by Theorem 1. To apply the theorem, take Λ′ to be
concentrated on (ǫ, ǫ) and apply Lemma 1. The resulting test with rejection region Sα is then
easily seen to be the consonant sum test given by (5). 
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Proof of Proposition 4. The proof is analogous to the proof of Proposition 3, except that
Λ′ puts equal mass at (ǫ, ǫ) and (−ǫ,−ǫ). 
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Table 1. The critical values r(0.90), r(0.95), and r(0.99) as functions of the correlation coef-
ficient ρ. These values were obtained from B = 106 Monte Carlo simulations
ρ r(0.90) r(0.95) r(0.99) ρ r(0.90) r(0.95) r(0.99)
0.0 1.982 2.290 2.878
−0.1 1.804 2.075 2.596 0.1 2.152 2.498 3.153
−0.2 1.617 1.853 2.313 0.2 2.314 2.700 3.421
−0.3 1.423 1.622 2.031 0.3 2.467 2.892 3.687
−0.4 1.228 1.392 1.743 0.4 2.611 3.071 3.943
−0.5 1.024 1.160 1.452 0.5 2.746 3.240 4.194
−0.6 0.819 0.930 1.161 0.6 2.872 3.401 4.427
−0.7 0.614 0.696 0.866 0.7 2.988 3.548 4.634
−0.8 0.409 0.465 0.581 0.8 3.095 3.683 4.827
−0.9 0.205 0.231 0.291 0.9 3.197 3.807 5.003
−1.0 0.000 0.000 0.000 1.0 3.290 3.920 5.152
Table 2. Comparison of empirical familywise error rate, denoted by αˆ, and empirical power,
denoted by βˆ, attained by different methods as functions of the correlation ρ and the true
means (θ1, θ2)
ρ (θ1, θ2) Holm maxT Sum ConS Holm maxT Sum ConS
αˆ βˆ
0.0 (0.0,0.0) 0.0249 0.0251 0.0159 0.0242 0 0 0 0
0.0 (3.0,0.0) 0.0215 0.0215 0.0241 0.0242 0.778 0.779 0.549 0.660
0.0 (3.0,1.5) 0 0 0 0 0.829 0.829 0.852 0.881
0.0 (3.0,3.0) 0 0 0 0 0.951 0.951 0.976 0.978
0.5 (0.0,0.0) 0.0235 0.0250 0.0218 0.0246 0 0 0 0
0.5 (3.0,0.0) 0.0237 0.0237 0.0240 0.0240 0.778 0.787 0.411 0.446
0.5 (3.0,1.5) 0 0 0 0 0.793 0.801 0.735 0.758
0.5 (3.0,3.0) 0 0 0 0 0.898 0.904 0.925 0.931
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Figure 1: The rejection regions for the test of Proposition 2 and its improvement in Proposition 3 with
nominal level α = 0.05 when ρ = 0. The test of Proposition 2 rejects for points to the right of and
above the dashed line with intercept 2.326 and slope −1. The improved test of Proposition 3 rejects for
points to the right of and above the solid curve defined by (5) with s(0.95) = 1.985 and z1−α = 1.645.
The region which leads to at least one individual rejection by the improved test but not by the standard
test is shaded.
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Figure 2: The rejection regions for the test of the two-sided version of Proposition 2 based on the
absolute sum, and its improvement in Proposition 4 with nominal level α = 0.05 when ρ = 0. The
absolute sum test rejects for points outside the dashed band. The improved test rejects for points
outside the solid ‘band’. The region which leads to at least one individual rejection by the improved
test but not by the absolute test is shaded.
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